articleNew England Journal of MedicineJul 11, 2012BRONZE OA

Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana

Centers for Disease Control and Prevention · Centers for Disease Control and Prevention · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Preexposure prophylaxis with antiretroviral agents has been shown to reduce the transmission of human immunodeficiency virus (HIV) among men who have sex with men; however, the efficacy among heterosexuals is uncertain.

Methods

We randomly assigned HIV-seronegative men and women to receive either tenofovir disoproxil fumarate and emtricitabine (TDF-FTC) or matching placebo once daily. Monthly study visits were scheduled, and participants received a comprehensive package of prevention services, including HIV testing, counseling on adherence to medication, management of sexually transmitted infections, monitoring for adverse events, and individualized counseling on risk reduction; bone mineral density testing was performed semiannually in a subgroup of participants.

Citation impact

2,021
total citations
FWCI
100.80
Percentile
100%
References
12
Citations per year

Authors

24

Topics & keywords

Keywords
  • Medicine
  • Emtricitabine
  • Placebo
  • Resistance mutation
  • Adverse effect
  • Pre-exposure prophylaxis
  • Internal medicine
  • Nausea
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding